Vitargent Biotechnology Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series B2

  • Investors
  • 11

Vitargent Biotechnology General Information

Description

Developer of biotechnology platform intended to serve testing organizations. The company offers technology with transgenic medaka and zebrafish fish embryos for conducting toxic laboratory tests, enabling industries such as cosmetics, skincare, food, and beverage conglomerate to safeguard their products against harmful chemicals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Corporate Office
  • Unit 203, 16 West
  • Number 16 Science Park West Avenue
  • Hong Kong
  • Hong Kong
+852 2393 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitargent Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B2) 04-Jul-2018 Completed Generating Revenue
4. Later Stage VC (Series B1) 01-Mar-2018 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 26-May-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Jan-2015 Completed Startup
1. Accelerator/Incubator 15-Oct-2010 Completed Startup
To view Vitargent Biotechnology’s complete valuation and funding history, request access »

Vitargent Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology platform intended to serve testing organizations. The company offers technology with transgen
Biotechnology
Hong Kong, Hong Kong
17 As of 2022
00000000000

000 00

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut lab
0000000000000
Saclay, France
000 As of 0000
000000&0

000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
0000 000000000
Antrim, United Kingdom
0000 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vitargent Biotechnology Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CIS Bio International Formerly PE-Backed Saclay, France 000 000000&0
Randox Corporation Antrim, United Kingdom 0000 0000000000
Parexel International Private Equity-Backed Durham, NC 00000 00000 000000000 00 00000
You’re viewing 3 of 3 competitors. Get the full list »

Vitargent Biotechnology Patents

Vitargent Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201811234-D0 Determination of safety grade or score of a product Inactive 09-Jul-2018 000000000
US-20200013133-A1 Computing system and method for determining safety index of product Inactive 09-Jul-2018 000000000
EP-3594887-A1 Computing system and method for determining safety index of product Inactive 09-Jul-2018 000000000 0
US-20170356900-A1 Toxicant assays for cosmetic products Inactive 08-Jun-2016 00000000000
US-20170356895-A1 Toxicant assays for consumable products Inactive 08-Jun-2016 G01N33/02
To view Vitargent Biotechnology’s complete patent history, request access »

Vitargent Biotechnology Executive Team (5)

Name Title Board Seat Contact Info
Jimmy Tao Chief Executive Officer
Xueping Chen Ph.D Co-Founder, Chief Technology Officer & Director
Eric Chen Co-Founder, Chief Commercial Officer & Director
Jeffrey Cheung Co-Founder, Chief Financial Officer & Director, Corporate Service
You’re viewing 4 of 5 executive team members. Get the full list »

Vitargent Biotechnology Board Members (1)

Name Representing Role Since
Peter Liu WI Harper Group Chairman 000 0000
To view Vitargent Biotechnology’s complete board members history, request access »

Vitargent Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitargent Biotechnology Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bridgefield Capital Management PE/Buyout Minority 000 0000 000000 0
HeungKong Group Limited Corporation Minority 000 0000 000000 0
Leohe Capital Venture Capital Minority 000 0000 000000 0
Paeonia Group Family Office Minority 000 0000 000000 0
PwC China Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Vitargent Biotechnology FAQs

  • When was Vitargent Biotechnology founded?

    Vitargent Biotechnology was founded in 2010.

  • Who is the founder of Vitargent Biotechnology?

    Xueping Chen Ph.D, Eric Chen, and Jeffrey Cheung are the founders of Vitargent Biotechnology.

  • Who is the CEO of Vitargent Biotechnology?

    Jimmy Tao is the CEO of Vitargent Biotechnology.

  • Where is Vitargent Biotechnology headquartered?

    Vitargent Biotechnology is headquartered in Hong Kong, Hong Kong.

  • What is the size of Vitargent Biotechnology?

    Vitargent Biotechnology has 17 total employees.

  • What industry is Vitargent Biotechnology in?

    Vitargent Biotechnology’s primary industry is Biotechnology.

  • Is Vitargent Biotechnology a private or public company?

    Vitargent Biotechnology is a Private company.

  • What is Vitargent Biotechnology’s current revenue?

    The current revenue for Vitargent Biotechnology is 000000.

  • Who are Vitargent Biotechnology’s investors?

    Bridgefield Capital Management, HeungKong Group Limited, Leohe Capital, Paeonia Group, and PwC China are 5 of 11 investors who have invested in Vitargent Biotechnology.

  • Who are Vitargent Biotechnology’s competitors?

    CIS Bio International, Randox, and Parexel International are competitors of Vitargent Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »